Status:
COMPLETED
Kinematic Assessment In Multiple Sclerosis
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Collaborating Sponsors:
University of Leeds
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Multiple sclerosis (MS) affects more than a 120,000 people in the United Kingdom and is the commonest neurological condition in young adults. MS causes a number of symptoms including weakness, altered...
Eligibility Criteria
Inclusion
- Age above 18 years at the time of enrolment into the study
- Participants with a confirmed diagnosis of MS that have entered the primary or secondary progressive stage for at least 12 months
- Participants must be able to comply with the terms and methods of the protocol
- Study specific written informed consent has been obtained
Exclusion
- Age below 18 years at the time of enrolment into the study
- Participants with a diagnosis of RRMS
- Participants unable to comply with the terms or methods of the protocol
- Participants who report any cognitive or memory impairment
- Participants with significant co-morbidities that affect their upper limb function i.e. stroke etc.
Key Trial Info
Start Date :
November 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2021
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04283071
Start Date
November 7 2019
End Date
October 30 2021
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom